Kymera Therapeutics, Inc.
KYMR
$43.87
$2.054.90%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.49% | -11.03% | 30.37% | 53.70% | 38.73% |
| Total Receivables | 2,247.42% | 885.22% | -94.95% | -65.14% | -58.66% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 66.41% | 21.27% | 76.26% | 23.68% | 0.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 38.62% | -6.76% | 25.89% | 51.38% | 36.33% |
|
|
|||||
| Total Current Assets | 38.62% | -6.76% | 25.89% | 51.38% | 36.33% |
| Net Property, Plant & Equipment | -5.80% | -2.80% | -3.18% | 9.01% | 20.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.77% | 14.82% | -2.33% | -32.72% | -10.15% |
| Total Assets | 36.93% | 5.77% | 69.87% | 87.34% | 41.94% |
|
|
|||||
| Total Accounts Payable | -11.20% | 50.66% | -15.35% | 30.45% | 73.83% |
| Total Accrued Expenses | 17.65% | 44.51% | 2.96% | 0.56% | 5.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.07% | 33.87% | 106.65% | 257.47% | 226.99% |
| Total Finance Division Other Current Liabilities | 106.40% | -47.22% | -64.07% | -26.77% | -20.89% |
| Total Other Current Liabilities | 106.40% | -47.22% | -64.07% | -26.77% | -20.89% |
| Total Current Liabilities | 40.87% | 5.08% | -20.92% | 5.33% | 13.81% |
|
|
|||||
| Total Current Liabilities | 40.87% | 5.08% | -20.92% | 5.33% | 13.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.91% | -5.24% | -4.70% | -2.42% | 6.32% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -84.56% |
| Total Liabilities | 13.11% | -15.90% | -21.22% | -9.52% | -3.70% |
|
|
|||||
| Common Stock & APIC | 42.77% | 24.31% | 71.84% | 72.23% | 44.96% |
| Retained Earnings | -44.33% | -41.58% | -42.18% | -32.43% | -34.06% |
| Treasury Stock & Other | 113.29% | 96.74% | -169.02% | 178.82% | 42.26% |
| Total Common Equity | 41.84% | 10.55% | 111.56% | 125.75% | 57.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 41.84% | 10.55% | 111.56% | 125.75% | 57.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 41.84% | 10.55% | 111.56% | 125.75% | 57.30% |
|
|
|||||